Off label use: FDA reporting patterns
856,373 FDA FAERS reports mention Off label use. 454,472 reports have a serious outcome flag.
Medicines named as suspect
- Infliximab: 52,833 reports
- Rituximab: 47,446 reports
- Denosumab: 34,827 reports
- Methotrexate: 25,945 reports
- Etanercept: 22,464 reports
- Adalimumab: 22,276 reports
- Vedolizumab: 21,730 reports
- Prednisone: 20,122 reports
- Tocilizumab: 19,342 reports
- Lenalidomide: 18,061 reports
- Mycophenolate Mofetil: 16,972 reports
- Hydroxychloroquine: 16,029 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.